CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Michelle A. Kendall

OPENALEX: A5052412044↗ORCID: 0000-0001-9160-4544↗

Affiliations

Organizations

University of California, Santa Barbaraauthorship · US

Public evidence

2 connected articles

Integrated transcriptome and cell phenotype analysis suggest involvement of PARP1 cleavage, Hippo/Wnt, TGF-β and MAPK signaling pathways in ovarian cancer cells response to cannabis and PARP1 inhibitor treatment.2024 · Europe PMC Phytocannabinoid Compositions from Cannabis Act Synergistically with PARP1 Inhibitor against Ovarian Cancer Cells In Vitro and Affect the Wnt Signaling Pathway.2022 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Michelle A. Kendall - Medical Cannabis Research Engine